NFKB1 and melanoma: The table highlights the spectrum of tumor types in which IVM has demonstrated activity, including colorectal, breast, lung, and melanoma models, and outlines the principal mechanisms reported, such as apoptosis induction, mitochondrial dysfunction, oxidative stress, and modulation of signaling pathways like NF-κB and mTOR/STAT3.